# HPV type16/18 L1 protein

## Cervarix (HPV,Government) 0.5mL/dose

| TAH Drug Code      | [ICER0](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ICER0)                                                                                                                                                                                                                                                              |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of cervical cancer in females 10-25 years, by protecting against incident & persistent infections, cytological abnormalities including atypical squamous cells of undetermined significance (ASC-US) & cervical intraepithelial neoplasia (CIN), CIN1 & pre-cancerous lesions (CIN2 & CIN3) caused by HPV Types 16 & 18. |
| Dosing             | IM, 0.5mL, > or = 15 years 3 doses at 0, 1, and 6 months. 9-14 years can take 3 doses at 0, 1, and 6 months or 2 doses at 0 and 6-12 months.                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Subjects with known hypersensitivity to any component of Cervarix.                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Headache, GI disturbances, itch, rash, myalgia, arthralgia, inj site reactions, fatigue, fever.                                                                                                                                                                                                                                     |
| Pregnancy          | No (Limited) Human Data â€“ Probably Compatible                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                       |

